Cancer in Africa
ESMO Consensus conferences
Maintaining success, reducing treatment burden, focusing on survivorship
Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes
Prevalence of depression in adults with cancer
The contribution of molecular epidemiology to the identification of human carcinogens
Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy
Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas
An open-label study of lapatinib in women with HER-2-negative early breast cancer
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
The need for accredited training in gynaecological oncology
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone
Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension
mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
Treatment and complications in elderly stage III colon cancer patients in the Netherlands
Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases
Disease volumes as a marker for patient response in malignant pleural mesothelioma
Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy†
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma
Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma
Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma†
Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin
Cruciferous vegetables intake and the risk of colorectal cancer
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma†
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma
Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosis
Blood pressure monitoring in patients receiving bevacizumab
Response to letter titled
Comment on
Reply to ‘Comment on
Are PubMed alone and English literature only enough for a meta-analysis?
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer